In December 2019, a new virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus disease 2019 (COVID-19) emerged in Wuhan, Hubei Province, China. SARS-CoV-2 is transmitted through respiratory droplets and object infected with droplets containing the virus. The diagnosis is made employing quantitative reverse transcriptase polymerase chain reaction to identify the viral nucleic acid in respiratory specimens or blood samples.
Cutaneous manifestations in COVID‐19. the experiences of Barcelona and Rome / Tammaro, A.; Adebanjo, G. A. R.; Parisella, F. R.; Pezzuto, A.; Rello, J.. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - 34:7(2020), pp. 1-7. [10.1111/jdv.16530]
Cutaneous manifestations in COVID‐19. the experiences of Barcelona and Rome
Tammaro, A.
;Adebanjo, G. A. R.;
2020
Abstract
In December 2019, a new virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing Coronavirus disease 2019 (COVID-19) emerged in Wuhan, Hubei Province, China. SARS-CoV-2 is transmitted through respiratory droplets and object infected with droplets containing the virus. The diagnosis is made employing quantitative reverse transcriptase polymerase chain reaction to identify the viral nucleic acid in respiratory specimens or blood samples.File | Dimensione | Formato | |
---|---|---|---|
Tammaro_Cutaneous_2020.pdf
solo gestori archivio
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
6.04 MB
Formato
Adobe PDF
|
6.04 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.